Page last updated: 2024-09-03

ta 993 and thromboxane b2

ta 993 has been researched along with thromboxane b2 in 1 studies

Compound Research Comparison

Studies (ta 993)	Trials (ta 993)	Recent Studies (post-2010) (ta 993)	Studies (thromboxane b2)	Trials (thromboxane b2)	Recent Studies (post-2010) (thromboxane b2)
10	0	0	7,483	715	485

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ikeo, T; Karasawa, T; Katoh, M; Odawara, A; Takagi, M; Watanabe, A	1

Other Studies

1 other study(ies) available for ta 993 and thromboxane b2

Article	Year
Inhibitory effects of TA-993 and its metabolite MB3 on platelet activation induced by collagen and U-46619 in human platelets. Biological & pharmaceutical bulletin, 2001, Volume: 24, Issue:5 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Triphosphate; Calcium; Collagen; Diltiazem; Humans; Male; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Thromboxane B2	2001

Article

Year

Inhibitory effects of TA-993 and its metabolite MB3 on platelet activation induced by collagen and U-46619 in human platelets.

Biological & pharmaceutical bulletin, 2001, Volume: 24, Issue:5

Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Triphosphate; Calcium; Collagen; Diltiazem; Humans; Male; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Thromboxane B2

2001